Thomas Rohrer

Thomas is the Vice President, Bioconjugation at Veranova. He brings over 40 years of experience and a comprehensive understanding of biological process development and clinical manufacturing, including 30 years of licensed biological manufacturing. Throughout his career, he has successfully delivered complex biological programs for both clinical and commercial applications, including mammalian, microbial, vaccine, and gene therapy drug substances.

He spent 16 years at Lonza, where he led teams across several locations and departments, including Biopharmaceutical Manufacturing, Antibody Drug Conjugation, Biochemical Technologies, Project Evaluation and Commercial Development. His extensive industry experience also includes Director of Process Development at Human Genome Sciences (later acquired by GSK), Otsuka America Pharmaceutical, Guidepoint Global LLC, Gentz Biopharmaceutical Consulting LLC, and most recently as Senior Director of Bioconjugate Technology Support at Samsung Biologics.